Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Veziris

Showing results (31-40 of 114) with videos related to

Pageof 12
Sort By:
Antimicrobial Agents and Chemotherapy|July 10, 2013
Impact of fluoroquinolone resistance on bactericidal and sterilizing activity of a moxifloxacin-containing regimen in murine tuberculosisAurélie Fillion, Alexandra Aubry, Florence Brossier, et al.
Expert Review of Anti-Infective Therapy|October 4, 2016
Infections caused by Mycobacterium abscessus: epidemiology, diagnostic tools and treatmentFaiza Mougari, Lorenzo Guglielmetti, Laurent Raskine, et al.
The Journal of Infection|February 14, 2012
Increase in primary drug resistance of Mycobacterium tuberculosis in younger birth cohorts in FranceVanina Meyssonnier, Nicolas Veziris, Sylvaine Bastian, et al.
Dermatology Online Journal|March 24, 2011
Successful treatment of nodular lymphangitis due to Mycobacterium chelonae in two immunosuppressed patientsPierre Schneider, Gentiane Monsel, Nicolas Veziris, et al.
Antimicrobial Agents and Chemotherapy|September 7, 2006
Combinations of R207910 with drugs used to treat multidrug-resistant tuberculosis have the potential to shorten treatment durationNacer Lounis, Nicolas Veziris, Aurélie Chauffour, et al.
Presse Medicale (Paris, France : 1983)|April 17, 2012
Voluminous pseudotumor due to Mycobacterium malmoenseLeslie Grammatico-Guillon, Philippe Lanotte, Frederic Bastides, et al.
Presse Medicale (Paris, France : 1983)|April 19, 2014
Cavitary pulmonary disease in a patient treated with natalizumabAdèle de Masson, Elisabeth Maillart, Nicolas Veziris, et al.
Microbiology Spectrum|January 12, 2023
Five-Hour Detection of Intestinal Colonization with Extended-Spectrum-β-Lactamase-Producing <i>Enterobacteriaceae</i> Using the β-Lacta Phenotypic Test: the BLESSED StudySalah Gallah, Maximilien Scherer, Thierry Collin, et al.
Plos Neglected Tropical Diseases|November 19, 2013
Resistance of M. leprae to quinolones: a question of relativity?Nicolas Veziris, Aurélie Chauffour, Sylvie Escolano, et al.
Antimicrobial Agents and Chemotherapy|December 24, 2014
Molecular diagnosis of fluoroquinolone resistance in Mycobacterium tuberculosisChristine Bernard, Nicolas Veziris, Florence Brossier, et al.
Pageof 12

Showing results (31-40 of 114) with videos related to

Sort By:
Pageof 12
Antimicrobial Agents and Chemotherapy|July 10, 2013
Impact of fluoroquinolone resistance on bactericidal and sterilizing activity of a moxifloxacin-containing regimen in murine tuberculosisAurélie Fillion, Alexandra Aubry, Florence Brossier, et al.
Expert Review of Anti-Infective Therapy|October 4, 2016
Infections caused by Mycobacterium abscessus: epidemiology, diagnostic tools and treatmentFaiza Mougari, Lorenzo Guglielmetti, Laurent Raskine, et al.
The Journal of Infection|February 14, 2012
Increase in primary drug resistance of Mycobacterium tuberculosis in younger birth cohorts in FranceVanina Meyssonnier, Nicolas Veziris, Sylvaine Bastian, et al.
Dermatology Online Journal|March 24, 2011
Successful treatment of nodular lymphangitis due to Mycobacterium chelonae in two immunosuppressed patientsPierre Schneider, Gentiane Monsel, Nicolas Veziris, et al.
Antimicrobial Agents and Chemotherapy|September 7, 2006
Combinations of R207910 with drugs used to treat multidrug-resistant tuberculosis have the potential to shorten treatment durationNacer Lounis, Nicolas Veziris, Aurélie Chauffour, et al.
Presse Medicale (Paris, France : 1983)|April 17, 2012
Voluminous pseudotumor due to Mycobacterium malmoenseLeslie Grammatico-Guillon, Philippe Lanotte, Frederic Bastides, et al.
Presse Medicale (Paris, France : 1983)|April 19, 2014
Cavitary pulmonary disease in a patient treated with natalizumabAdèle de Masson, Elisabeth Maillart, Nicolas Veziris, et al.
Microbiology Spectrum|January 12, 2023
Five-Hour Detection of Intestinal Colonization with Extended-Spectrum-β-Lactamase-Producing <i>Enterobacteriaceae</i> Using the β-Lacta Phenotypic Test: the BLESSED StudySalah Gallah, Maximilien Scherer, Thierry Collin, et al.
Plos Neglected Tropical Diseases|November 19, 2013
Resistance of M. leprae to quinolones: a question of relativity?Nicolas Veziris, Aurélie Chauffour, Sylvie Escolano, et al.
Antimicrobial Agents and Chemotherapy|December 24, 2014
Molecular diagnosis of fluoroquinolone resistance in Mycobacterium tuberculosisChristine Bernard, Nicolas Veziris, Florence Brossier, et al.
Pageof 12